Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
1 other identifier
observational
2,008
12 countries
80
Brief Summary
The purpose of the Trevo® Retriever Registry is to collect real world performance data of the Trevo Retriever which is intended to restore blood flow in the neurovasculature by removing thrombus in patients experiencing ischemic stroke.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2013
Longer than P75 for all trials
80 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 25, 2013
CompletedFirst Submitted
Initial submission to the registry
January 15, 2014
CompletedFirst Posted
Study publicly available on registry
January 20, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 28, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 28, 2017
CompletedResults Posted
Study results publicly available
June 24, 2020
CompletedJune 24, 2020
June 1, 2020
4.1 years
January 15, 2014
February 14, 2019
June 11, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Revascularization Status Assessment at the End of the Trevo Retriever Procedure Using the Modified TICI Score
The primary end point is revascularization based on modified Thrombolysis in Cerebral Infarction score (mTICI). Per protocol, successful revascularization is defined as having a modified TICI score ≥2b at the end of the procedure. Modified TICI Scale (mTICI Scale) Grade 0 - No Perfusion Grade 1 - Penetration with Minimal Perfusion Grade 2 - Partial Perfusion Grade 2a - Only partial filling (\< 50%) of the entire vascular territory is visualized. Grade 2b - Filling of \> 50% all of the expected vascular territory is visualized, but the filling is slower than normal. Grade 3 - Complete Perfusion
Post Procedure
Secondary Outcomes (4)
Modified Rankin Scale (mRS) Assessment at 90 Days
90 days
All Cause Mortality
90 days
Device and Procedure Related Serious Adverse Events (SAEs)
90 days
Neurological Deterioration at 24 Hours
24 hours
Study Arms (1)
Mechanical thrombectomy, Trevo Retriever
Mechanical thrombectomy, Trevo Retriever
Eligibility Criteria
Acute ischemic stroke patients who may be referred for mechanical thrombectomy is used to removed thrombus in the neurovasculature
You may qualify if:
- Subjects experiencing acute ischemic stroke who are eligible for restoration of blood flow using any approved Trevo Retriever in the neurovasculature to remove thrombus
- Trevo Retriever is the initial mechanical neuro-thrombectomy device used to remove the thrombus
- Signed Informed Consent obtained
- Subject willing to comply with the protocol follow-up requirements
- Anticipated life expectancy of at least 3 months
You may not qualify if:
- The subject is participating in another mechanical neuro-thrombectomy device trial or any other clinical trial where the study procedure or treatment might confound the study end point.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (80)
Banner Desert Medical Center
Mesa, Arizona, 85202, United States
St. Joseph's Hospital and Medical Center - Dignity Health (BNI Phoenix)
Phoenix, Arizona, 85013, United States
Eden Medical Center
Castro Valley, California, 94546, United States
St. Jude Medical Center
Fullerton, California, 92835, United States
Scripps Memorial Hospital
La Jolla, California, 92037, United States
UCLA Medical Center
Los Angeles, California, 90095, United States
UCI Medical Center
Orange, California, 92868, United States
California Pacific Medical Center (CPMC)
San Francisco, California, 94114, United States
Good Samaritan Hospital Regional Medical Center
San Jose, California, 95124, United States
Los Robles Hospital and Medical Center
Thousand Oaks, California, 91360, United States
Yale University / Yale-New Haven Hospital
New Haven, Connecticut, 06520, United States
Christiana Hospital
Newark, Delaware, 19718, United States
Memorial Regional Hospital
Hollywood, Florida, 33021, United States
Baptist Medical Center - Jacksonville
Jacksonville, Florida, 32207, United States
University of Miami (Jackson Memorial)
Miami, Florida, 33126, United States
Florida Hospital
Orlando, Florida, 32803, United States
Center for Advanced Research Excellence (St. Mary's Medical Center)
West Palm Beach, Florida, 33409, United States
Emory University at Grady Memorial Hospital
Atlanta, Georgia, 30303, United States
WellStar Kennestone Hospital
Marietta, Georgia, 30060, United States
Advocate Christ Lutheran Hospital
Park Ridge, Illinois, 60068, United States
Peoria Radiology Research & Education Foundation
Peoria, Illinois, 61637, United States
University of Iowa
Iowa City, Iowa, 52242, United States
Baptist Health Lexington
Lexington, Kentucky, 40503, United States
University of Kentucky
Lexington, Kentucky, 40536, United States
Maine Medical Center
Portland, Maine, 04102, United States
University of Maryland Medical Center
Baltimore, Maryland, 21201, United States
Johns Hopkins University
Baltimore, Maryland, 21287, United States
UMass Memorial
Worcester, Massachusetts, 01655, United States
McLaren Flint Regional Medical Center
Flint, Michigan, 48532, United States
St. Joseph Mercy
Pontiac, Michigan, 48341, United States
Capital Health System
Trenton, New Jersey, 08638, United States
Buffalo General Medical Center
Buffalo, New York, 14203, United States
Mount Sinai Health System
New York, New York, 10029, United States
Vassar Brothers Medical Center
Poughkeepsie, New York, 12601, United States
Mission Hospital
Asheville, North Carolina, 28801, United States
Ohio State University Medical Center
Columbus, Ohio, 43210, United States
Riverside Methodist Hospital/ Ohio Health Research Institute
Columbus, Ohio, 43214, United States
Oregon Stroke Center, Oregon Health & Science University (OHSU)
Portland, Oregon, 97239, United States
Abington Memorial Hospital
Abington, Pennsylvania, 19001, United States
Drexel University
Philadelphia, Pennsylvania, 19107, United States
UPMC Presbyterian
Pittsburgh, Pennsylvania, 15213, United States
Erlanger Hospital
Chattanooga, Tennessee, 37377, United States
University of Tennessee Medical Center Knoxville
Knoxville, Tennessee, 37920, United States
Methodist Healthcare - Memphis Hospitals
Memphis, Tennessee, 38120, United States
Valley Baptist Harlingen
Harlingen, Texas, 78550, United States
Houston Methodist Hospital
Houston, Texas, 77030, United States
Memorial Hermann Hospital
Houston, Texas, 77030, United States
Toronto Western Hospital
Toronto, M5T 2S8, Canada
University Hospital Hradec Králové
Hradec Králové, 50005, Czechia
CHU Bordeaux
Bordeaux, 33000, France
Hôpital Henri Mondor
Créteil, 94000, France
GRENOBLE
Grenoble, 38700, France
CHU Lille
Lille, 59037, France
Hopital Dupuytren
Limoges, 59037, France
CHU Nancy
Nancy, 54035, France
La Pitié Salpêtrière
Paris, 75013, France
La Fondation Ophtalmologique Adolphe de Rothschild
Paris, 75019, France
CHU de Tours
Tours, 37044, France
Klinikum Augsburg
Augsburg, 86156, Germany
Vivantes Klinikum Neukölln
Berlin, 12351, Germany
Klinikum Dortmund
Dortmund, 44137, Germany
Uniklinik Erlangen
Erlangen, 91504, Germany
Universitätsklinikum Freiburg
Freiburg im Breisgau, 79106, Germany
Uniklinik Heidelberg
Heidelberg, 69120, Germany
Uniklinik Homburg
Homburg/ Saar, 66421, Germany
UKSH; Lübeck
Lübeck, 23538, Germany
Uniklinik Mainz- Mainz
Mainz-GE, 55101, Germany
National Institute of Clinical Neurosciences
Budapest, 1145, Hungary
Spedali Civili di Brescia
Brescia, 25123, Italy
Ospedale San Martino
Genova, 16132, Italy
National Neuroscience Institute,
Singapore, 308433, Singapore
Kyungpook National University Hospital
Jungni I Gu, 700-721, South Korea
Seoul National University Bundang Hospital
Seongnam-si, 463-707, South Korea
Hospital Universitari de Bellvitge
L'Hospitalet de Llobregat, Barcelona, 08907, Spain
Hospital Universitario Donostia
Donostia / San Sebastian, 20014, Spain
Hospital Universitario De La Princesa
Madrid, 28006, Spain
Hospital Universitario Central De Asturias
Oviedo, 33006, Spain
Son Espases de Mallorca
Palma de Mallorca, 7120, Spain
Kantonsspital Aarau
Aarau, 5000, Switzerland
Siriraj Hospital
Bangkok, 10700, Thailand
Related Publications (2)
Bartolini B, Krajina A, Budzik R, Gupta R, Nogueira RG, Malek A, Sarraj A, English J, Narata AP, Taqi M, Miller T, Grobelny T, Baxter B, Jenkins P, Liebeskind DS, Veznedaroglu E; Trevo Registry Investigators. Outcomes of Mechanical Thrombectomy of Acute Basilar Artery Occlusion Due to Underlying Intracranial Atherosclerotic Disease. Stroke Vasc Interv Neurol. 2022 Nov 18;3(2):e000429. doi: 10.1161/SVIN.122.000429. eCollection 2023 Mar.
PMID: 41585922DERIVEDNogueira RG, Haussen DC, Liebeskind D, Jovin TG, Gupta R, Jadhav A, Budzik RF, Baxter B, Krajina A, Bonafe A, Malek A, Narata AP, Shields R, Zhang Y, Morgan P, Bartolini B, English J, Frankel MR, Veznedaroglu E; Trevo Registry and DAWN Trial Investigators. Stroke Imaging Selection Modality and Endovascular Therapy Outcomes in the Early and Extended Time Windows. Stroke. 2021 Jan;52(2):491-497. doi: 10.1161/STROKEAHA.120.031685. Epub 2021 Jan 12.
PMID: 33430634DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Minyi Ji, Biostatistician, Clinical Evidence
- Organization
- Stryker Neurovascular
Study Officials
- PRINCIPAL INVESTIGATOR
Erol Veznedaroglu, MD
Drexel Neurosciences Institute,Philadelphia
- PRINCIPAL INVESTIGATOR
Ronald Budzik, MD
Riverside Methodist Hospital/ Ohio Health Research Institute, Columbus, OH
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 90 Days
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 15, 2014
First Posted
January 20, 2014
Study Start
November 25, 2013
Primary Completion
December 28, 2017
Study Completion
December 28, 2017
Last Updated
June 24, 2020
Results First Posted
June 24, 2020
Record last verified: 2020-06